Efficacy, safety, and immunosuppressant adherence in stable liver transplant patients converted from a twice-daily tacrolimus-based regimen to once-daily tacrolimus extended-release formulation

Once-Daily Prolonged-Release Tacrolimus (ADVAGRAF) Versus Twice-Daily Tacrolimus (PROGRAF) in Liver Transplantation

(2010) P. Trunečka et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Once Daily Calcineurin Inhibitor Monotherapy in Pediatric Liver Transplantation

(2010) U. D. Ekong et al.   AMERICAN JOURNAL OF TRANSPLANTATION

IMPROVEMENT OF GRAFT FUNCTION AND CARDIOVASCULAR RISK FACTORS AFTER ONCE DAILY TACROLIMUS CONVERSION IN STABLE KIDNEY TRANSPLANT PATIENTS

(2010) F. Tinti et al.   TRANSPLANTATION

The Psychometric Properties and Practicability of Self-Report Instruments to Identify Medication Nonadherence in Adult Transplant Patients: A Systematic Review

(2010) Fabienne Dobbels et al.   TRANSPLANTATION

Safety of Conversion From Twice-Daily Tacrolimus (Prograf) to Once-Daily Prolonged-Release Tacrolimus (Advagraf) in Stable Liver Transplant Recipients

(2010) C. Comuzzi et al.   TRANSPLANTATION PROCEEDINGS

Conversion From Twice-Daily to Once-Daily Tacrolimus Administration in Liver Transplant Patient

(2010) M. Merli et al.   TRANSPLANTATION PROCEEDINGS

Evaluation of Clinical Safety of Conversion to Advagraf Therapy in Liver Transplant Recipients: Observational Study

(2009) L.M. Marin-Gomez et al.   TRANSPLANTATION PROCEEDINGS